137 related articles for article (PubMed ID: 6093442)
1. Prognostic factors in testicular germ cell tumours. Experiences from 1058 consecutive cases.
Vaeth M; Schultz HP; Von Der Maase H; Engelholm SA; Krag Jacobsen G; Nørgaard-Pedersen B
Acta Radiol Oncol; 1984; 23(4):271-85. PubMed ID: 6093442
[TBL] [Abstract][Full Text] [Related]
2. Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.
Nørgaard-Pedersen B; Schultz HP; Arends J; Brincker H; Krag Jacobsen G; Lindeløv B; Rørth M; Svennekjaer IL
Acta Radiol Oncol; 1984; 23(4):287-94. PubMed ID: 6208749
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
[TBL] [Abstract][Full Text] [Related]
4. Does extragonadal presentation impart a worse prognosis to abdominal germ-cell tumours?
McAleer JJ; Nicholls J; Horwich A
Eur J Cancer; 1992; 28A(4-5):825-8. PubMed ID: 1381929
[TBL] [Abstract][Full Text] [Related]
5. Germ cell tumours of testis: prognostic factors and results.
Nikzas D; Champion AE; Fox M
Eur Urol; 1990; 18(4):242-7. PubMed ID: 1705226
[TBL] [Abstract][Full Text] [Related]
6. Seminoma testis with elevated serum beta-HCG--a category of germ-cell cancer between seminoma and nonseminoma.
Dieckmann KP; Düe W; Bauer HW
Int Urol Nephrol; 1989; 21(2):175-84. PubMed ID: 2473044
[TBL] [Abstract][Full Text] [Related]
7. Human chorionic gonadotropin-positive seminoma: is this a special type of seminoma with a poor prognosis?
Scheiber K; Mikuz G; Frommhold H; Bartsch G
Prog Clin Biol Res; 1985; 203():97-104. PubMed ID: 3832120
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of human chorionic gonadotropin-producing seminoma treated by postoperative radiotherapy.
Mirimanoff RO; Sinzig M; Krüger M; Miralbell R; Thöni A; Ries G; Bosset JF; Bernier J; Bolla M; Nguyen TD
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(1):17-23. PubMed ID: 8365938
[TBL] [Abstract][Full Text] [Related]
9. Testicular seminoma: histological findings and their prognostic significance for stage II disease.
Evensen JF; Fosså SD; Kjellevold K; Lien HH
J Surg Oncol; 1987 Nov; 36(3):166-9. PubMed ID: 3682835
[TBL] [Abstract][Full Text] [Related]
10. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
11. Testicular germ cell tumours in Denmark 1976-1980. Pathology of 1058 consecutive cases.
Krag Jacobsen G; Barlebo H; Olsen J; Schultz HP; Starklint H; Søgaard H; Vaeth M
Acta Radiol Oncol; 1984; 23(4):239-47. PubMed ID: 6093440
[TBL] [Abstract][Full Text] [Related]
12. [Clinical presentation of testicular germinal cancer].
Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
[TBL] [Abstract][Full Text] [Related]
13. Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3).
Seidel C; Daugaard G; Nestler T; Tryakin A; Fedyanin M; Fankhauser C; Hermanns T; Aparicio J; Heinzelbecker J; Paffenholz P; Heidenreich A; De Giorgi U; Cathomas R; Lorch A; Fingerhut A; Gayer F; Bremmer F; Giannatempo P; Necchi A; Aurilio G; Casadei C; Tran B; Dieckmann KP; Brito M; Ruf C; Oing C; Bokemeyer C
Eur J Cancer; 2020 Jun; 132():127-135. PubMed ID: 32361383
[TBL] [Abstract][Full Text] [Related]
14. Single institutional experience with non-seminomatous germ cell tumours of the testis: local perspectives on a curable cancer.
Rosenthal MA; Stuart-Harris RC; Tiver KW; Langlands AO; Kefford RF
Aust N Z J Med; 1991 Dec; 21(6):857-62. PubMed ID: 1726358
[TBL] [Abstract][Full Text] [Related]
15. Elevated human chorionic gonadotropin concentrations in the testicular vein and in peripheral venous blood in seminoma patients. An analysis of various parameters.
Hartmann M; Pottek T; Bussar-Maatz R; Weissbach L
Eur Urol; 1997; 31(4):408-13. PubMed ID: 9187899
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in seminomas with special respect to HCG: results of a prospective multicenter study. Seminoma Study Group.
Weissbach L; Bussar-Maatz R; Löhrs U; Schubert GE; Mann K; Hartmann M; Dieckmann KP; Fassbinder J
Eur Urol; 1999 Dec; 36(6):601-8. PubMed ID: 10559615
[TBL] [Abstract][Full Text] [Related]
17. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival in patients treated for testicular seminoma.
Hannun Y; Vugrin D
J Surg Oncol; 1990 Mar; 43(3):177-80. PubMed ID: 2314105
[TBL] [Abstract][Full Text] [Related]
19. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
20. Testicular seminoma: analysis of treatment and failure for stage II disease.
Evensen JF; Fossa SD; Kjellevold K; Lien HH
Radiother Oncol; 1985 Aug; 4(1):55-61. PubMed ID: 4035002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
